Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Novogene Europe announced the installation of its fifth Illumina NovaSeq X Plus sequencing system, expanding high-throughput sequencing capacity to meet surging European demand. This strategic enhancement solidifies Novogene's position as Europe's ...
read more
Tuesday, January 10, 2023
Novotech an Asia Pacific centered biotech CRO announced the acquisition of CBR International, a global product development, clinical oversight and strategic regulatory operations group.
read more
Wednesday, September 11, 2024
Novotech announced the appointment of Dr. Yooni Kim as a new Executive position of Managing Director for the Asia-Pacific (APAC) region, effective September 1, 2024.
read more
Novozymes Biopharma, part of Novozymes A/S, a world leader in bioinnovation, has today announced a collaboration with Janssen Research & Development, LLC (Janssen). The agreement will enable Janssen to evaluate Novozymes Biopharma’s engineered ...
read more
Novozymes Biopharma has entered a new collaborative research agreement with one of the world’s top vaccine companies. The partnership will enable the company to evaluate Novozymes Biopharma's modified recombinant human albumin (rAlbumin) Veltis ...
read more
For the first time, Novozymes Biopharma, part of Novozymes A/S, a world leader in bioinnovation, will showcase its biological-based ingredients and technologies at CPhI China. The company’s Hyasis™, Recombumin® and biocatalysis products will feature ...
read more
Work to be showcased at the 2013 Controlled Release Society annual meeting shows that Hyasis®, the Bacillus-derived Hyaluronic acid from Novozymes Biopharma, helps formulation scientists meet emerging challenges in drug development with controlled ...
read more
A novel ophthalmic solution from R-Tech Ueno (Tokyo, Japan) made using Novozymes Biopharma’s recombinant human albumin has recently obtained FDA approval to undergo Phase I/II clinical trials in the United States.
read more
Monday, December 30, 2019
NPXe Limited has filed a voluntary petition to reorganize under Chapter 11 of the Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware.
read more
Wednesday, October 09, 2019
NSF International has acquired a majority interest in Amarex Clinical Research, a clinical stage CRO headquartered in Germantown, Maryland.
read more
NSF International is now offering pharma biotech consulting and training services from its Gurugram, India office.
read more
To mark its 10th anniversary, NuChem Sciences, Canada's largest contract research organization (CRO) in drug discovery chemistry, recently inaugurated its new laboratories located on Dobrin Street in Montreal.
read more
Tuesday, February 18, 2020
Nucleus Biologics announced a complete line of cGMP grade media and a new supplement to enable improved insulin response and standardized processing of human pancreatic islets and beta cells.
read more
Numerate, Inc., a computational drug design company applying artificial intelligence (AI) at cloud scale to transform small molecule drug discovery, announced the formation of a multi-year agreement with Takeda Pharmaceutical Company Limited under ...
read more
Wednesday, September 17, 2025
NurExone Biologic announced that its U.S. subsidiary, Exo-Top Inc., is planning to establish its first U.S. commercial exosome production facility in Indianapolis, Indiana.
read more